Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 41

Trial Status

Completed3

Role Distribution

Principal Investigator2
Other Roles1
PI Rate67%

Activity Timeline

Clinical Trials (3)

NCT06202560Not ApplicableCompleted
Effectiveness and Safety of Tofacitinib in Patients With Recalcitrant Frontal Fibrosing Alopecia : A Pilot Study
Frontal Fibrosing AlopeciaLichen Planopilaris of Scalp
StudydirectorStart date: 2023-11-29
NCT03926845Not ApplicableCompleted
Efficacy and Tolerability of an Isobutylamido-thiazolyl-resorcinol Cream 0.2% for Facial Hyperpigmentation
Facial Hyperpigmentation
PrincipalinvestigatorStart date: 2019-04-29
NCT03800979Phase 4Completed
Effectiveness and Safety of Tofacitinib in Patients With Extensive and Recalcitrant Alopecia Areata
Alopecia Areata
PrincipalinvestigatorStart date: 2019-01-12

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT06202560Not ApplicableStudyDirector

Effectiveness and Safety of Tofacitinib in Patients With Recalcitrant Frontal Fibrosing Alopecia : A Pilot Study

Frontal Fibrosing AlopeciaLichen Planopilaris of Scalp
Completed
NCT03926845Not ApplicablePrincipalInvestigator

Efficacy and Tolerability of an Isobutylamido-thiazolyl-resorcinol Cream 0.2% for Facial Hyperpigmentation

Facial Hyperpigmentation
Completed
NCT03800979Phase 4PrincipalInvestigator

Effectiveness and Safety of Tofacitinib in Patients With Extensive and Recalcitrant Alopecia Areata

Alopecia Areata
Completed

All 3 trials loaded